Hold at $504 with tiered buy triggers pending MACD/50 SMA confirmation
Hold at $504. Structural thesis remains compelling—$365B cash earning ~5%, 22.3% net margins, Greg Abel's first net equity purchase in 14 quarters, and 10-11B/quarter operating cash flow—but momentum has not stabilized (MACD histogram at -1.30, below 10 EMA and Bollinger midline). The tiered framework resolves tension between aggressive (opportunity cost of sitting in cash) and conservative (Forward P/E 22.94x pricing in earnings normalization) positions. The 8/13 lesson (price-only triggers create avoidable opportunity cost) and 8/12 lesson (RS vs SPY should be a trigger) are both addressed. Hard stop $489 (1.5 ATR below entry, below 200 SMA at $491) limits downside on any new adds. Catalysts that shift to Overweight: buyback resumption, MACD bullish crossover, forward EPS upward revisions. Catalysts that warrant Underweight: sustained close below 200 SMA on >4M volume, or weekly RS breakdown vs SPY.
| Position | Action |
|---|---|
| 50 SMA reversal at $499 on >4M volume with RSI reclaiming 50 OR MACD histogram turn-positive | Add quarter-size position |
| Close >10 EMA ($512) on >4M volume | Add one-third size position |
| Close >$529 on >5M volume | Add final third size position |
| Close >$545 on any trigger | Trim 20-25% profit-taking |
BRK-B at $504 represents a structural transition opportunity under new CEO Greg Abel, who has shifted from Buffett's cash-hoarding posture to aggressive capital deployment—making this a BUY on weakness rather than a stock to be cautious about.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 47.60 | neutral |
| MACD Line | 4.66 | neutral |
| MACD Signal | 5.97 | neutral |
| MACD Histogram | -1.30 | bearish |
| 10 EMA | 512.05 | bearish |
| 50 SMA | 499.03 | bullish |
| 200 SMA | 491.60 | bullish |
| Bollinger Upper | 532.31 | neutral |
| Bollinger Middle | 507.92 | neutral |
| Bollinger Lower | 483.52 | neutral |
| ATR (14) | 8.16 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close >$512 on >4M volume
Then: Third-size add
Q2 2026 earnings demonstrate robust underlying operating performance, not business deterioration
↩ rebuts: “Bear's forward P/E of 22.94x suggesting earnings decline”
· concedes: The forward P/E of 22.94x does suggest near-term earnings normalization compared to the flattered TTM figure; The 10 EMA roll-over and MACD cross-down are valid deceleration signals, though not regime changes; Waiting for a 50 SMA retest at $499 would provide a marginally better entry point; The technical report assigns HOLD with a constructive bias, not an outright BUY
The bull case is built on narrative rather than evidence—Berkshire's "miracle quarter" was flattered by investment portfolio mark-to-market gains, not operational strength, and at $504 with a Forward P/E of 22.94x, PEG of 10.06, and accelerating concentration risk in rate-sensitive assets, the risk/reward skews against the buyer.
· concedes: BRK-B is a great company; 107% earnings growth did occur (though driven by investment gains, not operations); Stock is above 50 and 200 SMAs; New CEO is actively deploying capital (though creating concentration risk); Insider buying did occur (though statistically insignificant); Macro environment can be supportive (with significant internal contradictions in bull's own narrative)
→ vs conservative: Textbook confirmation candle waiting is analysis paralysis, not discipline — insider alignment cluster and structural thesis provide the entry edge
→ vs conservative: Forward P/E spread not a warning sign but rather reflects absence of mark-to-market investment gains in TTM; conservative camp anchoring to noisy metric
→ vs conservative: 50 SMA retest waiting ignores that 50 SMA at $499 and 200 SMA at $491.60 are already providing rising dynamic support
→ vs conservative: Conservative framework treating high-quality compounder like a meme stock; opportunity cost of wait-and-see is enormous
→ vs conservative: Half-sizing suggestion is a hedge against the very setup being captured; want full position conviction on retest
→ vs neutral: Patience stance underestimates how constructive the tape is; insider buying provides near-term technical floor
→ vs neutral: Waiting for bullish reversal candle with volume above 4 million or break above $529 on 5 million misses the structural thesis already validating
→ vs neutral: Consolidation is healthy; next leg up will be violent once 50 SMA retest completes
| neutral |
| Close | 504.03 | neutral |
| Open | 507.23 | neutral |
| High | 509.16 | neutral |
| Low | 503.77 | neutral |
| Volume | 3.95M | neutral |
Support: 499.03 · 494.79 · 495.45 · 491.6 · 488.35 · 483.52 | Resistance: 537.74 · 532.31 · 529.42 · 524.61 · 512.05 · 507.92
BRK-B exhibits a corrective pullback within a constructive medium-term structure: the 50 SMA (499.03) and 200 SMA (491.60) remain in bullish alignment, but the 10 EMA (512.05) has rolled over as overhead resistance and the MACD crossed below its signal line. Key levels to watch are 499 for the first support test and 512 for potential trend resumption, with the recommendation being HOLD pending a clean retest or reclaim of these levels.
Market Capitalization
~1.079 Trillion
TTM P/E Ratio
12.68x
Forward P/E
22.94x
PEG Ratio
10.06
EPS (TTM)
$39.74
Forward EPS
$21.97
Beta
0.607
52-Week High
$537.74
52-Week Low
$464.01
50-Day Moving Avg
$498.45
200-Day Moving Avg
$491.52
Current Price
~$504
Revenue (TTM)
$384.687B
Gross Profit
$116.685B
EBITDA
$130.683B
Net Income (TTM)
$85.768B
Profit Margin
22.30%
Operating Margin
32.56%
Return on Equity (ROE)
12.12%
Return on Assets (ROA)
6.01%
Total Assets (Q2 2026)
$1,263.07B
Cash & Cash Equivalents (Q2 2026)
$40.61B
Other Short-Term Investments (Q2 2026)
$324.91B
Cash + ST Investments (Q2 2026)
~$365.51B
Investments & Advances (Q2 2026)
$685.67B
Net PPE (Q2 2026)
$244.14B
Goodwill & Intangibles (Q2 2026)
$117.12B
Total Debt (Q2 2026)
$128.60B
Net Debt (Q2 2026)
$87.99B
Stockholders' Equity (Q2 2026)
$747.91B
Tangible Book Value (Q2 2026)
$630.79B
Tangible Book Value Per Share
~$440
Current Ratio (Q2 2026)
2.89x
Debt-to-Equity Ratio
17.14
Q2 2026 Revenue
$117.89B
Q2 2026 Net Income
$25.77B
Q2 2026 EPS (Diluted)
$11.91
Q1 2026 Revenue
$92.07B
Q1 2026 Net Income
$10.18B
Q1 2026 EPS (Diluted)
$4.68
Q4 2025 Revenue
$111.44B
Q4 2025 Net Income
$19.20B
Q3 2025 EPS
$14.28
Q2 2025 Revenue
$98.88B
Q2 2025 Net Income
$12.46B
Q2 2025 EPS (Diluted)
$5.73
Q1 2025 EPS (Diluted)
$2.13
Q2 2026 Operating Cash Flow
$11.22B
Q2 2026 Free Cash Flow
$5.57B
Q2 2026 CapEx
-$5.65B
Q2 2026 Buybacks
$4.21B
Annual Operating Cash Flow
~$40-44B
Annual Free Cash Flow
~$20-24B
Strengths
Concerns
Berkshire Hathaway (BRK-B) presents a compelling risk/reward profile with a fortress balance sheet featuring over $365 billion in liquid assets, diversified cash-generative businesses spanning insurance, railroads, energy and manufacturing, and low beta (0.607) characteristics. The TTM P/E of 12.68x appears attractive relative to the S&P 500's typical 18-22x range, though the elevated Forward P/E of 22.94x signals analyst expectations for earnings normalization as investment gains unwind. The company demonstrates exceptional profitability with 22.30% net margins and 12.12% ROE, supported by robust annual operating cash flow of approximately $43 billion, while the Q2 2026 initiation of buybacks ($4.21B) marks a notable shift in capital return policy under new leadership.
Macro: Higher-for-longer Fed regime: Polymarket prices 85% probability of zero rate cuts in 2026 (down 1.2pp week-over-week). Market firmly pricing hold through year-end with 0% implied odds on 6+ cumulative cuts. Weak July U.S. retail sales (below consensus) consistent with 'soft landing / no cuts' pattern. Inflation risk remains the dominant macro concern—tariff evasion crackdowns and shipping chaos flagged as upside CPI risks by Barron's. Soft landing confidence high with 8% U.S. recession probability (down 0.5pp). Oil rally supports energy holdings (Occidental, Chevron). Nasdaq slipping on retail-sales gloom; Dow Jones futures positioned for a run with Nvidia in a buy area. Risk appetite is selective, not broadly euphoric—consistent with defensive quality rotation that historically benefits BRK-B.